2Li MK, Folpe AL. CDX-2, a new marker for adenocarcinoma of gastrointestinal origin. Adv Anat Patho1,2004,11 : 101-105.
3Drummond F, Put W, Fox M, et al. Cloning and chromosome assignment of the human CDX2 gene. Ann Hum Genet, 1997,61 :393-400.
4Tot T. Identifying colorectal metastases in liver biopsies: the novel CDX2 antibody is less specific than the cytokeratin 20 +/7-phenotype. Med Sci Monit, 2004,10: 139-143.
5Su YC, Hsu YC, Chai CY. Role of TYF-1, CK20, and CK7 immunohistochemistry for diagnosis of primary and secondary lung adenocarcinoma [ J ]. Kaohsiung J Med Sci. 2006, 22 ( 1 ) : 14 - 19.
6Vang R, Gown AM, Wu IS, et al. Immunohistochemical expression of CDX2 in primary ovarian mucinous tumors and metastatic mucinous carcinomas involving the ovary: comparison with CK20 and correlation with coordinate expression of CK7 [J]. Mod Pathol, 2006, 19( 11 ) : 1421 - 1428.
7Park SY,Kim HS, Hong EK, et al. Expression of cytokeratins 7 and 20 in primary carcinomas of the stomach and colorectum and their value in the differential diagnosis of metastatic carcinomas to the ovary [J]. Hum Pathol, 2002, 33(11) : 1078- 1085.
8Rubin BP, Skarin AT, Pisick E, et al. Use of cytokeratins 7 and 20 in determining the origin of metastatic carcinoma of unknown primary, with special emphasis on lung cancer [J]. Eur J Cancer Prey. 2001, 10( 1 ) : 77 - 82.
9Tot. T Patterns of distribution of cytokeratins 20 and 7 in special types of invasive breast carcinoma: a study of 123 cases [J]. Ann Diagn Pathol, 1999, 3(6) : 350 - 356.
10Cathro HP, Stoler MH. Expression of cytokeratins 7 and 20 in ovarian neoplasia [J]. Am J Clin Pathol, 2002, 117(6): 944- 951.
